
{"data":{"variantAnnotations":[{"cases":260,"pvalue":"0.0029","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476225,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157387","current":true,"text":"rs4148740","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":12,"pvalue":"0.05","race":"Asian","literatureUrl":"/pmid/12012142","literature":"12012142","id":1446901561,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"},{"url":"/haplotype/PA165980636","current":true,"text":"CYP2C19*3","resource":"PharmGKB"}],"characteristics":"endpoints: oral clearance, half-life time, maximum plasma concentration and time to peak plasma concentration"},{"cases":50,"pvalue":"0.025","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617161,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"},{"url":"/haplotype/PA165980636","current":true,"text":"CYP2C19*3","resource":"PharmGKB"}],"characteristics":"endpoint: amitriptyline concentration, *2/*2 + *2/*3 vs *1/*1 (*1/*2+*1/*3 vs *1/*1 not significant p=0.54) (no CYP modulating co-medication)"},{"cases":73,"pvalue":"0.442","race":"Unknown","literatureUrl":"/pmid/26704739","literature":"26704739","id":1448276439,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA164713257","current":true,"text":"Selective serotonin reuptake inhibitors","resource":"PharmGKB"},{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA10074","current":true,"text":"escitalopram","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451333","current":true,"text":"sertraline","resource":"PharmGKB"},{"url":"/chemical/PA451791","current":true,"text":"trimipramine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"no","variants":[{"url":"/variant/PA166157317","current":true,"text":"rs2032583","resource":"PharmGKB"}],"characteristics":"Inpatients at the Max Planck Institute of Psychiatry (MPI-P) in Munich"},{"cases":807,"pvalue":"0.01","race":"White","literatureUrl":"/pmid/18070221","literature":"18070221","id":1183617418,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449409","current":true,"text":"doxepin","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA450322","current":true,"text":"maprotiline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA144614922","current":true,"text":"opipramol","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"Rotterdam Study (population based study), some patients used more than on antidepressant, further co-medication status was not reported, side effects were counted as the switch to a different antidepressant within the first 45 days"},{"cases":23,"race":"Faroese","literatureUrl":"/pmid/17764479","literature":"17764479","id":1446903476,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["dosage"],"significance":"no","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"patients; no known CYP2D6 inhibitors were taken as co-medication, PM daily dose 5-80 mg/day, EM 10-100"},{"cases":69,"pvalue":"0.004","race":"Unknown","literatureUrl":"/pmid/16044105","literature":"16044105","id":827808349,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","other"],"significance":"yes","variants":[{"url":"/variant/PA166154053","current":true,"text":"rs4244285","resource":"PharmGKB"}],"characteristics":"Psychiatric outpatients with steady-state serum drug concentration measurements and no CYP-effecting co-medications"},{"cases":257,"pvalue":"0.0053","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476235,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157445","current":true,"text":"rs10280101","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":195,"pvalue":"0.004","race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1446903345,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"},{"url":"/haplotype/PA165948317","current":true,"text":"CYP2D6*9","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases, endpoint: MR AT/OH-AT, CYP2D6 PM vs carriers of *9, *10, *1, *2, *1xN, *2xN (study included only 1 *4/*10 no further IM, so subjects with at least one functional or two decreased function alleles)"},{"cases":195,"pvalue":"0.002","race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1446903345,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"},{"url":"/haplotype/PA165948317","current":true,"text":"CYP2D6*9","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases, endpoint: MR NT/OH-NT, CYP2D6 PM vs carriers of *9, *10, *1, *2, *1xN, *2xN (study included only 1 *4/*10 no further IM, so subjects with at least one functional or two decreased function alleles)"},{"cases":50,"pvalue":"0.026","race":"White","literatureUrl":"/pmid/16638956","literature":"16638956","id":827777223,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"no","variants":[{"url":"/variant/PA166157316","current":true,"text":"rs2032582","resource":"PharmGKB"}],"characteristics":"medium-grade depressive disorder, unadjusted p-value"},{"cases":50,"pvalue":"0.048","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617183,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"},{"url":"/haplotype/PA165980636","current":true,"text":"CYP2C19*3","resource":"PharmGKB"}],"characteristics":"endpoint: MR amitriptyline/nortriptyline, *1/*2+*1/*3 vs *1/*1 (no CYP modulating co-medication)"},{"cases":50,"pvalue":"0.001","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617183,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"},{"url":"/haplotype/PA165980636","current":true,"text":"CYP2C19*3","resource":"PharmGKB"}],"characteristics":"endpoint: MR amitriptyline/nortriptyline, *2/*2+ *2/*3 vs *1/*1 (no CYP modulating co-medication)"},{"cases":257,"pvalue":"0.0046","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476245,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157428","current":true,"text":"rs7787082","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":807,"pvalue":"0.15","race":"White","literatureUrl":"/pmid/18070221","literature":"18070221","id":1446903849,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449409","current":true,"text":"doxepin","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA450322","current":true,"text":"maprotiline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA144614922","current":true,"text":"opipramol","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"no","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"The Rotterdam Study (population based study), some patients used more than on antidepressant, further co-medication status was not reported"},{"cases":21,"pvalue":"0.0005","race":"Faroese","literatureUrl":"/pmid/17764479","literature":"17764479","id":1183615381,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"patients, no known CYP2D6 inhibitors were taken as co-medication, EM MR NT/OH-NT= 0.34; PM = 3.07, ratio did not differ significantly for carriers of one functional allele (0.53) vs two functional allele (0.28)"},{"cases":50,"pvalue":"0.048","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617173,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: MR amitriptyline/nortriptyline, *1/*2+*1/*3 vs *1/*1 (no CYP modulating co-medication)"},{"cases":50,"pvalue":"0.001","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617173,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: MR amitriptyline/nortriptyline, *2/*2+ *2/*3 vs *1/*1 (no CYP modulating co-medication)"},{"cases":50,"pvalue":"0.000004","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617173,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: number of no function 2C19 alleles factor for MRAT/NT in multiple regression analysis (2D6 variation not associated) (no CYP modulating co-medication)"},{"cases":339,"pvalue":"0.025","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":655386253,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157336","current":true,"text":"rs2235015","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":807,"pvalue":"0.03","race":"White","literatureUrl":"/pmid/18070221","literature":"18070221","id":1183617426,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449409","current":true,"text":"doxepin","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA450322","current":true,"text":"maprotiline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA144614922","current":true,"text":"opipramol","resource":"PharmGKB"}],"phenotypeCategories":["dosage","efficacy"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"The Rotterdam Study (population based study), some patients used more than on antidepressant, further co-medication status was not reported, mean TCA dose was significantly lower (significant only at the 3rd and 4th prescription)"},{"cases":807,"pvalue":"0.05","race":"White","literatureUrl":"/pmid/18070221","literature":"18070221","id":1183617426,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449409","current":true,"text":"doxepin","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA450322","current":true,"text":"maprotiline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA144614922","current":true,"text":"opipramol","resource":"PharmGKB"}],"phenotypeCategories":["dosage","efficacy"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"some patients used more than on antidepressant, further co-medication status was not reported, mean TCA dose was lower not significant after the 4th prescription"},{"cases":1,"race":"White","literatureUrl":"/pmid/21614669","literature":"21614669","id":1183615533,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}]},{"cases":49,"pvalue":"0.00004","race":"White","literatureUrl":"/pmid/15590749","literature":"15590749","id":1183617453,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: side effect risk based on DOTES scale, compared 2C19*1/*2 + *2/*2 carrier with CYP2D6 *1/*1 + *1/*2 + *2/*1xN + *2/*2 + *1/*41 + *1/*10 + *2/*41 genotypes (n=13) vs 2C19*1/*1 with CYP2D6 *1/*4 + *2/*4 + *2/*5 + *4/*41 + *4/*10 (n=11)"},{"cases":1,"race":"White","literatureUrl":"/pmid/21614669","literature":"21614669","id":1446903324,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"intentionally overdosed on amitriptyline, prolonged rising of serum total amitriptyline and nortriptyline concentrations"},{"cases":50,"pvalue":"0.14","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617193,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"}],"characteristics":"endpoint: MR nortriptyline/hydroxy-nortriptyline, CYP2D6*1/*10 (n=23), *2/*10 (n=6) vs CYP2D6*1/*1, *1/*2, *2/*2 (total n=8) (no CYP modulating co-medication)"},{"cases":1,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623082,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"postmortem toxicology case - suicide"},{"cases":31,"race":"Mixed Population","literatureUrl":"/pmid/28350251","literature":"28350251","id":1448612606,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"not stated","variants":[],"characteristics":"n = 28; 90.32%) were classified as CYP2D6 NMs. Two patients (6.45%) were IM (one Caucasian and one Black African), and one Black African patient had a CYP2D6 genotype predictive of UM status. We did not observe any genotypes predictive of a PM phenotype"},{"cases":19,"pvalue":"0.036","race":"Faroese","literatureUrl":"/pmid/17764479","literature":"17764479","id":1183615397,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"patients, no known CYP2D6 inhibitors were taken as co-medication, EM MR AT/OH-AT =4, PM=10.7, ratio did not differ significantly for carriers of one functional allele (4.61) vs two functional allele (3.98)"},{"cases":261,"pvalue":"0.0029","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476266,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157386","current":true,"text":"rs4148739","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":100,"race":"Unknown","literatureUrl":"/pmid/22733128","literature":"22733128","id":1446903828,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449673","current":true,"text":"fluoxetine","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"no","variants":[{"url":"/variant/PA166157895","current":true,"text":"CYP2D6 poor metabolizers","resource":"PharmGKB"}],"characteristics":"No PM (no functional CYP2D6 allele) did discontinue treatment within 12 weeks, no assessment of plasma concentrations or efficacy, no separation between fluoxetine or amitriptyline treatment"},{"cases":359,"pvalue":"0.0062","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":655385916,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157317","current":true,"text":"rs2032583","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":49,"pvalue":"0.00001","race":"White","literatureUrl":"/pmid/15590749","literature":"15590749","id":1183617442,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"},{"url":"/haplotype/PA165988479","current":true,"text":"CYP2D6*1xN","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"},{"url":"/haplotype/PA165816584","current":true,"text":"CYP2D6*41","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"}],"characteristics":"endpoint: side effect risk based on DOTES scale with co-medication allowed (correcting for CYP2D6 affecting co-medication p=0.00005)"},{"cases":257,"pvalue":"0.0034","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476274,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157453","current":true,"text":"rs11983225","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":12,"pvalue":"0.05","race":"Asian","literatureUrl":"/pmid/12012142","literature":"12012142","id":1446901519,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"},{"url":"/haplotype/PA165980636","current":true,"text":"CYP2C19*3","resource":"PharmGKB"}],"characteristics":"endpoint: area under the plasma concentration time curve"},{"cases":74,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/8941025","literature":"8941025","id":1184467243,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA452229","current":true,"text":"antidepressants","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449233","current":true,"text":"desipramine","resource":"PharmGKB"},{"url":"/chemical/PA449673","current":true,"text":"fluoxetine","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"yes","variants":[{"url":"/haplotype/PA165816578","current":true,"text":"CYP2D6*3","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"},{"url":"/haplotype/PA165816581","current":true,"text":"CYP2D6*6","resource":"PharmGKB"}],"characteristics":"side effects reported for NT: Unsteadiness, nervousness, tinitus, tired, lethargic, sedation, agitation"},{"cases":16,"race":"White","literatureUrl":"/pmid/3571939","literature":"3571939","id":1446901646,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"not stated","variants":[{"url":"/variant/PA166157895","current":true,"text":"CYP2D6 poor metabolizers","resource":"PharmGKB"}],"characteristics":"endpoints: plasma amitriptyline and nortriptyline concentrantion, metabolic ratio of AT-OH + NT-OH/AT and AT-OH + NT-OH/AT+NT in 2 patients, phenotype with debrisoquine"},{"cases":807,"pvalue":"0.01","race":"White","literatureUrl":"/pmid/18070221","literature":"18070221","id":981476405,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449409","current":true,"text":"doxepin","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA450322","current":true,"text":"maprotiline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA144614922","current":true,"text":"opipramol","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"yes","variants":[{"url":"/variant/PA166156104","current":true,"text":"rs3892097","resource":"PharmGKB"}],"characteristics":"The Rotterdam Study (population based study), some patients used more than on antidepressant, further co-medication status was not reported"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623097,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":50,"pvalue":"0.068","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617206,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"}],"characteristics":"endpoint: MR nortriptyline/hydroxy-nortriptyline, CYP2D6*5/*10 (n=3), *10/*10 (n=2) vs CYP2D6*1/*1, *1/*2, *2/*2 (n=8) (no CYP modulating co-medication)"},{"cases":150,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":982029769,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/variant/PA166154053","current":true,"text":"rs4244285","resource":"PharmGKB"}],"characteristics":"Adult patients of a Psychiatric Hospital"},{"cases":32,"pvalue":"0.03","race":"Unknown","literatureUrl":"/pmid/1527229","literature":"1527229","id":1183684300,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449409","current":true,"text":"doxepin","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA451791","current":true,"text":"trimipramine","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/variant/PA166157895","current":true,"text":"CYP2D6 poor metabolizers","resource":"PharmGKB"}],"characteristics":"phenotyped with debrisoquine while on medication, 14 AT, 8 DOX, 6 TRI, 2 IMI, 2 CLO-per drug 50% subjects with drug level above therapeutic range and 50% with drug level in or below range, comedications allowed, serum concentrations of antidepressant + its active metabolite were measured, number PMs out of subjects with high drug level AT: 1 (7), DOX: 2 (4), IMI: 0 (1), TRI: 1 (3), CLO: 1 (1), statistics is given for the association 2PMs in control group with lower drug levels vs 8 PMs in group of higher drugs levels from the 10 PMs determined in cohort of 44 subjects"},{"cases":256,"pvalue":"0.0095","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476290,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157440","current":true,"text":"rs10248420","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623118,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165988480","current":true,"text":"CYP2D6*2xN","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":48,"pvalue":"0.059","race":"White","literatureUrl":"/pmid/15205367","literature":"15205367","id":827777557,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","other"],"significance":"yes","variants":[{"url":"/haplotype/PA165816510","current":true,"text":"CYP2C19*1A","resource":"PharmGKB"},{"url":"/haplotype/PA165816513","current":true,"text":"CYP2C19*2A","resource":"PharmGKB"}],"characteristics":"Psychiatric Inpatients (co-medications interfering with 2C19 or 2D6 were avoided), *1/*2 + *2/*2 (n=1) vs *1/*1"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623112,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":48,"pvalue":"0.033","race":"White","literatureUrl":"/pmid/15205367","literature":"15205367","id":827777552,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","other"],"significance":"yes","variants":[{"url":"/haplotype/PA165816510","current":true,"text":"CYP2C19*1A","resource":"PharmGKB"},{"url":"/haplotype/PA165816513","current":true,"text":"CYP2C19*2A","resource":"PharmGKB"}],"characteristics":"Psychiatric Inpatients (co-medications interfering with 2C19 or 2D6 were avoided), *1/*2 + *2/*2 (n=1) vs *1/*1"},{"cases":48,"pvalue":"0.65","race":"White","literatureUrl":"/pmid/15205367","literature":"15205367","id":1446903928,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"inpatients (co-medications interfering with 2C19 or 2D6 were avoided)amitriptyline+ nortriptyline concentrations "},{"cases":807,"pvalue":"0.03","race":"White","literatureUrl":"/pmid/18070221","literature":"18070221","id":981476423,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449048","current":true,"text":"clomipramine","resource":"PharmGKB"},{"url":"/chemical/PA449409","current":true,"text":"doxepin","resource":"PharmGKB"},{"url":"/chemical/PA449969","current":true,"text":"imipramine","resource":"PharmGKB"},{"url":"/chemical/PA450322","current":true,"text":"maprotiline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA144614922","current":true,"text":"opipramol","resource":"PharmGKB"}],"phenotypeCategories":["dosage","efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166156104","current":true,"text":"rs3892097","resource":"PharmGKB"}],"characteristics":"The Rotterdam Study (population based study) "},{"cases":49,"pvalue":"0.4","race":"White","literatureUrl":"/pmid/15590749","literature":"15590749","id":1446902772,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"no","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"},{"url":"/haplotype/PA165988479","current":true,"text":"CYP2D6*1xN","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"},{"url":"/haplotype/PA165816584","current":true,"text":"CYP2D6*41","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"}],"characteristics":"endpoint: response based on HAM-D scale "},{"cases":269,"pvalue":"6.6E-4","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476298,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157338","current":true,"text":"rs2235040","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":37,"pvalue":"1.0E-5","race":"White","literatureUrl":"/pmid/15205367","literature":"15205367","id":827777562,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","other"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"Psychiatric Inpatients (co-medications interfering with 2C19 or 2D6 were avoided), function was assessed per allele basis rather than genotype level such as *1/*4, *2/*4, *4/*41 was compared to *1/*1, *1/*2, *1/*41, *2/*41, NT concentration per dose unit and corrected for CYP2C19 was used for allele-specific change of concentration on identical background, which was 96% compared to *1 or *2, difference between the allele score of 1 , 1.5, 2 for NT concentration per dose p<0.05"},{"cases":150,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":1446903025,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"(information on co-medication was not collected), endpoint: amitriptyline concentrations (steady-state concentrations)"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623106,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165988479","current":true,"text":"CYP2D6*1xN","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":261,"pvalue":"0.002","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476308,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157458","current":true,"text":"rs12720067","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623130,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623124,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165948317","current":true,"text":"CYP2D6*9","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":150,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":1446903908,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["dosage"],"significance":"no","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816578","current":true,"text":"CYP2D6*3","resource":"PharmGKB"},{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"},{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"},{"url":"/haplotype/PA165816581","current":true,"text":"CYP2D6*6","resource":"PharmGKB"}],"characteristics":"(information on co-medication was not collected), endpoint: AT dose in mg/day, 0 functional alleles (93) or 1 functional allele (102), 2 functional alleles (120), 3 functional alleles (100)"},{"cases":1,"race":"White","literatureUrl":"/pmid/17008819","literature":"17008819","id":1183619031,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}]},{"cases":69,"pvalue":"0.001","race":"Unknown","literatureUrl":"/pmid/16044105","literature":"16044105","id":1446902626,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: log MR amitriptyline/nortriptyline, difference between genotype groups *1/*1 0.01, *1/*2 0.21, *2/*2 0.61"},{"cases":69,"pvalue":"0.019","race":"Unknown","literatureUrl":"/pmid/16044105","literature":"16044105","id":1446902626,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: log MR amitriptyline/nortriptyline, *1/*1 vs *2/*2"},{"cases":69,"pvalue":"0.004","race":"Unknown","literatureUrl":"/pmid/16044105","literature":"16044105","id":1446902626,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: log MR amitriptyline/nortriptyline, *1/*1 vs *1/*2"},{"cases":100,"pvalue":"0.01","race":"Unknown","literatureUrl":"/pmid/22733128","literature":"22733128","id":1183623532,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449673","current":true,"text":"fluoxetine","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165988479","current":true,"text":"CYP2D6*1xN","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA165988480","current":true,"text":"CYP2D6*2xN","resource":"PharmGKB"}],"characteristics":"differences across CYP2D6 groups in the rate of ADP discontinuation at week 4, groups: PMs CYP2D6=0+0.5, IMs CYP2D6=1, EMs CYP2D6=1.5+2, UMs CYP2D6=>2, no assessment of plasma concentrations or efficacy, no separation between fluoxetine or amitriptyline treatment"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623148,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165948092","current":true,"text":"CYP2D6*5","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/27097346","literature":"27097346","id":1448112308,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"},{"url":"/haplotype/PA165816577","current":true,"text":"CYP2D6*2","resource":"PharmGKB"},{"url":"/haplotype/PA166123327","current":true,"text":"CYP2D6*87","resource":"PharmGKB"},{"url":"/haplotype/PA166123328","current":true,"text":"CYP2D6*88","resource":"PharmGKB"},{"url":"/haplotype/PA166123329","current":true,"text":"CYP2D6*89","resource":"PharmGKB"},{"url":"/haplotype/PA166123330","current":true,"text":"CYP2D6*90","resource":"PharmGKB"},{"url":"/haplotype/PA166123331","current":true,"text":"CYP2D6*91","resource":"PharmGKB"},{"url":"/haplotype/PA166123333","current":true,"text":"CYP2D6*93","resource":"PharmGKB"},{"url":"/haplotype/PA166128737","current":true,"text":"CYP2D6*94","resource":"PharmGKB"},{"url":"/haplotype/PA166123336","current":true,"text":"CYP2D6*95","resource":"PharmGKB"},{"url":"/haplotype/PA166123338","current":true,"text":"CYP2D6*97","resource":"PharmGKB"},{"url":"/haplotype/PA166123339","current":true,"text":"CYP2D6*98","resource":"PharmGKB"}],"characteristics":"in-vitro"},{"cases":1,"race":"Unknown","literatureUrl":"/pmid/18359183","literature":"18359183","id":1183623913,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449273","current":true,"text":"dextromethorphan","resource":"PharmGKB"}],"phenotypeCategories":["toxicity"],"significance":"no","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}]},{"cases":150,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":1446903003,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"(information on co-medication was not collected), endpoint: MR amitriptyline/nortriptyline (steady-state concentrations)"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623142,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":150,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":1446903892,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816533","current":true,"text":"CYP2C19*17","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"(information on co-medication was not collected), endpoint: amitriptyline + nortriptyline serum concentration (at steady-state)"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623136,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816578","current":true,"text":"CYP2D6*3","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":7,"race":"White","literatureUrl":"/pmid/7159207","literature":"7159207","id":1446901072,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"not stated","variants":[{"url":"/variant/PA166157895","current":true,"text":"CYP2D6 poor metabolizers","resource":"PharmGKB"}],"characteristics":"phenotyped with debrisoquine, single dose, PMs had an absence of detectable amounts of hydroxy amitriptyline in blood, one PM showed decreased clearance of amitriptyline, a higher half-life time and higher AUC of amitriptyline and nortriptyline in blood"},{"cases":28,"pvalue":"0.001","race":"White","literatureUrl":"/pmid/15205367","literature":"15205367","id":827777575,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","other"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816582","current":true,"text":"CYP2D6*10","resource":"PharmGKB"}],"characteristics":"Psychiatric Inpatients (co-medications interfering with 2C19 or 2D6 were avoided), function was assessed per allele basis rather than genotype level such as *1/*10, *4/*10 was compared to *1/*1, *1/*4, *1/*2, *2/*4, NT concentration per dose unit and corrected for CYP2C19 was used for allele-specific change of concentration on identical background, which was 63% compared to *1 or *2, difference between the allele score of 1 , 1.5, 2 for NT concentration per dose p<0.05"},{"cases":1,"race":"Faroese","literatureUrl":"/pmid/17764479","literature":"17764479","id":1183615357,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"patients; no known CYP2D6 inhibitors were taken as co-medication"},{"cases":73,"pvalue":"0.513","race":"Unknown","literatureUrl":"/pmid/26704739","literature":"26704739","id":1448276512,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA164713257","current":true,"text":"Selective serotonin reuptake inhibitors","resource":"PharmGKB"},{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA10074","current":true,"text":"escitalopram","resource":"PharmGKB"},{"url":"/chemical/PA450657","current":true,"text":"nortriptyline","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451333","current":true,"text":"sertraline","resource":"PharmGKB"},{"url":"/chemical/PA451791","current":true,"text":"trimipramine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"no","variants":[{"url":"/variant/PA166157336","current":true,"text":"rs2235015","resource":"PharmGKB"}],"characteristics":"Inpatients at the Max Planck Institute of Psychiatry (MPI-P) in Munich"},{"cases":41,"pvalue":"1.0E-5","race":"White","literatureUrl":"/pmid/15205367","literature":"15205367","id":827777570,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","other"],"significance":"yes","variants":[{"url":"/haplotype/PA165816576","current":true,"text":"CYP2D6*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816584","current":true,"text":"CYP2D6*41","resource":"PharmGKB"}],"characteristics":"Psychiatric Inpatients (co-medications interfering with 2C19 or 2D6 were avoided), function was assessed per allele basis rather than genotype level such as *1/*41, *2/*41, *4/*41 was compared to *1/*1, *1/*2, *1/*4, *2/*4, NT concentration per dose unit and corrected for CYP2C19 was used for allele-specific change of concentration on identical background, which was 40% compared to *1 or *2, difference between the allele score of 1 , 1.5, 2 for NT concentration per dose p<0.05"},{"cases":280,"pvalue":"0.0071","race":"White","literatureUrl":"/pmid/18215618","literature":"18215618","id":981476212,"genes":[{"url":"/gene/PA267","current":true,"text":"ABCB1","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"},{"url":"/chemical/PA449015","current":true,"text":"citalopram","resource":"PharmGKB"},{"url":"/chemical/PA450801","current":true,"text":"paroxetine","resource":"PharmGKB"},{"url":"/chemical/PA451866","current":true,"text":"venlafaxine","resource":"PharmGKB"}],"phenotypeCategories":["efficacy"],"significance":"yes","variants":[{"url":"/variant/PA166157341","current":true,"text":"rs2235067","resource":"PharmGKB"}],"characteristics":"Depression"},{"cases":150,"race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":982029820,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/variant/PA166154147","current":true,"text":"rs12248560","resource":"PharmGKB"}],"characteristics":"Adult patients of a Psychiatric Hospital "},{"cases":177,"pvalue":"0.013","race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623160,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases, endpoint: MR AT/NT, *2/*2 vs *1/*1"},{"cases":177,"pvalue":"0.055","race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623160,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases, endpoint: MR AT/NT *1/*2 vs*1/*1"},{"cases":1,"race":"White","literatureUrl":"/pmid/15168101","literature":"15168101","id":1183617529,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"not stated","variants":[{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"one patient with 133% (increase) deviation from median dose-corrected plasma concentration for amitriptyline+nortriptyline"},{"cases":24,"pvalue":"0.0003","race":"Asian","literatureUrl":"/pmid/28296334","literature":"28296334","id":1448615842,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"},{"url":"/haplotype/PA165980636","current":true,"text":"CYP2C19*3","resource":"PharmGKB"}],"characteristics":"19–45 years old, healthy males with a body weight of not less than 60 kg"},{"cases":50,"pvalue":"0.025","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617143,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: amitriptyline concentration, *2/*2 + *2/*3 vs *1/*1 (*1/*2+*1/*3 vs *1/*1 not significant p=0.54) (no CYP modulating co-medication)"},{"cases":50,"pvalue":"0.017","race":"Asian","literatureUrl":"/pmid/12172336","literature":"12172336","id":1183617143,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"endpoint: number of no function 2C19 alleles factor for AT concentration in multiple regression analysis (2D6 variation not associated) (no CYP modulating co-medication)"},{"cases":21,"pvalue":"0.191","race":"Faroese","literatureUrl":"/pmid/17764479","literature":"17764479","id":1446903489,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"patients, no known CYP2D6 inhibitors were taken as co-medication, amitriptyline + nortriptyline/ dose "},{"cases":21,"pvalue":"0.556","race":"Faroese","literatureUrl":"/pmid/17764479","literature":"17764479","id":1446903489,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"patients, no known CYP2D6 inhibitors were taken as co-medication, AT/dose"},{"cases":21,"pvalue":"0.066","race":"Faroese","literatureUrl":"/pmid/17764479","literature":"17764479","id":1446903489,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165816579","current":true,"text":"CYP2D6*4","resource":"PharmGKB"}],"characteristics":"patients, no known CYP2D6 inhibitors were taken as co-medication, NT/dose"},{"cases":150,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":1446902977,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816533","current":true,"text":"CYP2C19*17","resource":"PharmGKB"}],"characteristics":"(information on co-medication was not collected), endpoint: MR amitriptyline/nortriptyline (steady-state concentrations)"},{"cases":31,"pvalue":"0.05","race":"Unknown","literatureUrl":"/pmid/20531370","literature":"20531370","id":1446902977,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"no","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165816533","current":true,"text":"CYP2C19*17","resource":"PharmGKB"}],"characteristics":"(information on co-medication was not collected), endpoint: MR amitriptyline/nortriptyline (steady-state concentrations), in CYP2D6 *1/*1 + CYP2C19*17/*17 vs CYP2D6 *1/*1 + CYP2C19*1/*1"},{"cases":195,"race":"White","literatureUrl":"/pmid/16024198","literature":"16024198","id":1183623154,"genes":[{"url":"/gene/PA128","current":true,"text":"CYP2D6","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK","toxicity"],"significance":"not stated","variants":[{"url":"/haplotype/PA165816581","current":true,"text":"CYP2D6*6","resource":"PharmGKB"}],"characteristics":"postmortem toxicology cases"},{"cases":49,"pvalue":"0.0197","race":"White","literatureUrl":"/pmid/15590749","literature":"15590749","id":1446903873,"genes":[{"url":"/gene/PA124","current":true,"text":"CYP2C19","resource":"PharmGKB"}],"chemicals":[{"url":"/chemical/PA448385","current":true,"text":"amitriptyline","resource":"PharmGKB"}],"phenotypeCategories":["metabolism/PK"],"significance":"yes","variants":[{"url":"/haplotype/PA165980634","current":true,"text":"CYP2C19*1","resource":"PharmGKB"},{"url":"/haplotype/PA165980635","current":true,"text":"CYP2C19*2","resource":"PharmGKB"}],"characteristics":"amitriptyline serum concentrations, *1/*2+*2/*2 in CYP2D6*1/*1 + *1/*2 + *2/*1xN + *2/*2 + *1/*41 + *1/*10 + *2/*41 carriers =105.8 microg/l; *1/*2+*2/*2 in CYP2D6 *1/*4 + *2/*4 + *2/*5 + *4/*41 + *4/*10 = 100.8 microg/l vs *1/*1 in CYP2D6*1/*1 + *1/*2 + *2/*1xN + *2/*2 + *1/*41 + *1/*10 + *2/*41 carriers = 70.5; *1/*1 in CYP2D6 *1/*4 + *2/*4 + *2/*5 + *4/*41 + *4/*10 = 93.5"}]},"status":"success"}


